Sridurga Mithraprabhu
- Hematology top 2%
- Multiple Myeloma Research and Treatments 26
- Acute Myeloid Leukemia Research 3
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 9
- Reproductive Medicine top 10%
- Sperm and Testicular Function 5
-
- Protein Degradation and Inhibitors 9
- Histone Deacetylase Inhibitors Research 7
- Extracellular vesicles in disease 4
-
- Peptidase Inhibition and Analysis 7
Sridurga Mithraprabhu
33 papers receiving 724 citations
Peers
Comparison fields: 5 of 65
- Hematology 362
- Cancer Research 172
- Reproductive Medicine 94
- Molecular Biology 506
- Oncology 149
Countries citing papers authored by Sridurga Mithraprabhu
This map shows the geographic impact of Sridurga Mithraprabhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sridurga Mithraprabhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sridurga Mithraprabhu more than expected).
Fields of papers citing papers by Sridurga Mithraprabhu
This network shows the impact of papers produced by Sridurga Mithraprabhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sridurga Mithraprabhu. The network helps show where Sridurga Mithraprabhu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sridurga Mithraprabhu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2021 | 15 | |
| 4 | 2021 | 4 | |
| 5 | 2021 | 1 | |
| 6 | 2021 | 20 | |
| 7 | 2021 | 9 | |
| 8 | 2020 | 2 | |
| 9 | 2019 | 46 | |
| 10 | 2019 | 34 | |
| 11 | 2018 | 5 | |
| 12 | 2018 | 17 | |
| 13 | 2016 | 7 | |
| 14 | 2014 | 23 | |
| 15 | 2014 | 144 | |
| 16 | 2014 | 77 | |
| 17 | 2011 | 29 | |
| 18 | 2010 | 54 | |
| 19 | 2010 | 16 | |
| 20 | 2009 | 37 |
About Sridurga Mithraprabhu
Sridurga Mithraprabhu is a scholar working on Hematology, Reproductive Medicine and Cancer Research, having authored 35 papers that have together received 732 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (26 papers), Protein Degradation and Inhibitors (9 papers), Cancer Genomics and Diagnostics (9 papers), Peptidase Inhibition and Analysis (7 papers), Histone Deacetylase Inhibitors Research (7 papers), Sperm and Testicular Function (5 papers), Extracellular vesicles in disease (4 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Hematology (362 citations), Cancer Research (172 citations) and Reproductive Medicine (94 citations). Sridurga Mithraprabhu has collaborated with scholars based in Australia, United States and India. Frequent co-authors include Andrew Spencer, Tiffany Khong, Anna Kalff, Kate L. Loveland, Annie Chow, Maoshan Chen, Chester Brown, John Reynolds, Antonia Reale and Sarah J. Meachem. Their work appears in journals such as Blood, International Journal of Molecular Sciences and Biology of Reproduction.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.